Two three-phase randomized controlled studies demonstrated that whether the PD-L1 CPS was more than five or not, ICI therapy plus chemotherapy compared with chemotherapy as first-line treatment significantly improved survival times in patients with advanced gastric or gastro-oesophagealjunction (GC/GEJ) adenocarcinoma cancer [9, 10]. The gene discussed is CD274; the disease is cancer.